Working Paper |
File Downloads |
Abstract Views |
Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
Acquisitions by EMNCs in Developed Markets: An Organisational Learning Perspective |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
21 |
Board Independence, Ownership Structure and the Valuation of IPOs in Continental Europe |
0 |
0 |
0 |
0 |
1 |
1 |
3 |
13 |
Cherry-picking or frog-kissing? A theoretical analysis of how investors select entrepreneurial ventures in thin venture capital markets |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
20 |
Clustering Financial Time Series by Network Community Analysis |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
Communities in Italian corporate networks |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
12 |
Creditor Heterogeneity and Absolute Priority Rule Violation in Entrepreneurial Finance |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
12 |
Cross-Border Investments and Venture Capital Exits in Europe |
0 |
0 |
0 |
0 |
1 |
2 |
7 |
20 |
Detecting abnormal changes in credit default swap spreads using matching-portfolio models |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
7 |
Does governmental venture capital spur invention and innovation? Evidence from young European biotech companies |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
38 |
Econometric study on the impact of EU loan guarantee financial instruments on growth and jobs of SMEs |
2 |
3 |
5 |
57 |
5 |
7 |
10 |
122 |
Importance of the Non-financial Value Added of Government and Independent Venture Capitalists |
0 |
0 |
0 |
53 |
0 |
1 |
1 |
185 |
Innovation and R&D investments by leveraged buyout companies in times of crisis |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
48 |
Innovation in Private Equity Leveraged Buyouts |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
11 |
Management innovation in leveraged buyout companies |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
35 |
Organizational Slack and Innovation Expenditures in Leveraged Buyout Companies |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
5 |
Self-selection of entrepreneurial firms in thin venture capital markets: Theory and empirical evidence |
0 |
0 |
0 |
0 |
1 |
1 |
3 |
13 |
Testing the Strategic Asset Allocation of Stabilization Sovereign Wealth Funds |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
7 |
The Effect of Sovereign Wealth Funds on the Credit Risk of their Portfolio Companies |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
17 |
The Effect of Venture Capital Financing on the Sensitivity to Cash Flow of Firm's Investments |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
13 |
The Productivity of European Life Insurers: Best-Practice Adoption vs. Innovation |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5 |
The Strategic Reallocation of IPO shares |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
15 |
The Use of Debt by Sovereign Wealth Funds |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
18 |
The different roles played by venture capital and private equity investors on the investment activity of their portfolio firms |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
30 |
The effects of EU-funded guarantee instruments of the performance of small and medium enterprises: Evidence from France |
1 |
1 |
2 |
31 |
1 |
2 |
4 |
67 |
The impact of government-supported participative loans on the growth of entrepreneurial ventures |
0 |
0 |
0 |
0 |
0 |
1 |
4 |
20 |
The patterns of venture capital investment in Europe |
0 |
0 |
0 |
0 |
1 |
1 |
8 |
47 |
The role of Governmental Venture Capital in the Venture Capital ecosystem: An organizational ecology perspective |
0 |
0 |
0 |
0 |
1 |
3 |
5 |
46 |
The value added by government venture capital funds compared with independent venture capital funds |
0 |
0 |
0 |
0 |
0 |
1 |
6 |
32 |
Venture Capital and the Investment Curve of Young High-Tech Companies |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
13 |
Venture capital financing and the growth of high-tech start-ups: Disentangling treatment from selection effects |
0 |
0 |
0 |
0 |
1 |
1 |
4 |
41 |
Venture capital investments and patenting activity of high-tech start-ups: a micro-econometric firm-level analysis |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
12 |
Venture capital investor type and the growth mode of new technology-based firms |
0 |
0 |
0 |
0 |
0 |
1 |
4 |
22 |
Which form of venture capital is most supportive of innovation? |
1 |
2 |
4 |
128 |
2 |
7 |
16 |
382 |
Which form of venture capital is most supportive of innovation? Evidence from European biotechnology companies |
0 |
0 |
0 |
24 |
1 |
2 |
3 |
226 |
Total Working Papers |
4 |
6 |
11 |
294 |
17 |
34 |
107 |
1,579 |